These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37622663)

  • 1. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.
    Marx N; Federici M; Schütt K; Müller-Wieland D; Ajjan RA; Antunes MJ; Christodorescu RM; Crawford C; Di Angelantonio E; Eliasson B; Espinola-Klein C; Fauchier L; Halle M; Herrington WG; Kautzky-Willer A; Lambrinou E; Lesiak M; Lettino M; McGuire DK; Mullens W; Rocca B; Sattar N;
    Eur Heart J; 2023 Oct; 44(39):4043-4140. PubMed ID: 37622663
    [No Abstract]   [Full Text] [Related]  

  • 2. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.
    ; ; Rydén L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes HP; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Uva MS; Taskinen MR; Tendera M; Tuomilehto J; Valensi P; Zamorano JL
    Diab Vasc Dis Res; 2014 May; 11(3):133-73. PubMed ID: 24800783
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendations for cardiovascular rehabilitation in diabetes mellitus].
    Camerini A; Chieffo C; Griffo R; Comaschi M; Gattone M; Mannucci E; Faglia E; Giorda C; Biorci ML; Fattirolli F;
    Monaldi Arch Chest Dis; 2003 Dec; 60(4):263-82. PubMed ID: 15061601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of cardiovascular diseases in patients with diabetes : ESC guidelines 2023].
    Marx N; Müller-Wieland D; Verket M; Schütt K
    Herz; 2024 Feb; 49(1):15-18. PubMed ID: 37878038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The '10 commandments' for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.
    Schütt K; Federici M; Verket M; Marx N; Müller-Wieland D
    Eur Heart J; 2024 Apr; 45(15):1298-1300. PubMed ID: 38195096
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD): a multicentre, pragmatic, cluster-randomised, controlled trial.
    Groenewegen A; Zwartkruis VW; Rienstra M; Zuithoff NPA; Hollander M; Koffijberg H; Oude Wolcherink M; Cramer MJ; van der Schouw YT; Hoes AW; Rutten FH; de Boer RA
    Lancet Public Health; 2024 Feb; 9(2):e88-e99. PubMed ID: 38134944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for risk factor treatment in the management of atrial fibrillation.
    Frenkel D; Aronow WS
    Hosp Pract (1995); 2020 Oct; 48(4):180-187. PubMed ID: 32552155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
    Herzog CA; Asinger RW; Berger AK; Charytan DM; Díez J; Hart RG; Eckardt KU; Kasiske BL; McCullough PA; Passman RS; DeLoach SS; Pun PH; Ritz E
    Kidney Int; 2011 Sep; 80(6):572-86. PubMed ID: 21750584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of 2016 ESC guidelines on heart failure, atrial fibrillation, dyslipidaemia and cardiovascular prevention.
    Claeys MJ; Mullens W; Vandekerckhove Y; Duytschaever M; De Maeyer C; Pasquet A
    Acta Cardiol; 2017 Dec; 72(6):610-615. PubMed ID: 28685644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies.
    Verdecchia P; Dagenais G; Healey J; Gao P; Dans AL; Chazova I; Binbrek AS; Iacobellis G; Ferreira R; Holwerda N; Karatzas N; Keltai M; Mancia G; Sleight P; Teo K; Yusuf S;
    J Hypertens; 2012 May; 30(5):1004-14. PubMed ID: 22495138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part II - Management of Various Cardiovascular Complications.
    Wang AY; Brimble KS; Brunier G; Holt SG; Jha V; Johnson DW; Kang SW; Kooman JP; Lambie M; McIntyre C; Mehrotra R; Pecoits-Filho R
    Perit Dial Int; 2015; 35(4):388-96. PubMed ID: 26228783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Bowel Disease and Cardiovascular Diseases.
    Chen B; Collen LV; Mowat C; Isaacs KL; Singh S; Kane SV; Farraye FA; Snapper S; Jneid H; Lavie CJ; Krittanawong C
    Am J Med; 2022 Dec; 135(12):1453-1460. PubMed ID: 36058305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interpretation of 2023 European Society of Cardiology (ESC) Guidelines for the management of cardiovascular disease in patients with diabetes].
    Yang J; Tang YD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Dec; 51(12):1273-1277. PubMed ID: 38123212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus.
    Fauchier L; Boriani G; de Groot JR; Kreutz R; Rossing P; Camm AJ
    Europace; 2021 Dec; 23(12):1873-1891. PubMed ID: 34411235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation.
    Paolillo S; Scardovi AB; Campodonico J
    Eur J Prev Cardiol; 2020 Dec; 27(2_suppl):27-34. PubMed ID: 33238738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial stiffness in patients with type 1 diabetes and its comparison to cardiovascular risk evaluation tools.
    Helleputte S; Van Bortel L; Verbeke F; Op 't Roodt J; Calders P; Lapauw B; De Backer T
    Cardiovasc Diabetol; 2022 Jun; 21(1):97. PubMed ID: 35681143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic atrial fibrillation among hospitalized patients: clinical correlates and in-hospital outcomes in Improving Care for Cardiovascular Disease in China-Atrial Fibrillation.
    Lin J; Wu XY; Long DY; Jiang CX; Sang CH; Tang RB; Li SN; Wang W; Guo XY; Ning M; Sun ZQ; Yang N; Hao YC; Liu J; Liu J; Du X; Fonarow GC; Smith SC; Lip GYH; Zhao D; Dong JZ; Ma CS
    Europace; 2023 Oct; 25(10):. PubMed ID: 37712716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dementia of cardiac disease.
    Muqtadar H; Testai FD; Gorelick PB
    Curr Cardiol Rep; 2012 Dec; 14(6):732-40. PubMed ID: 22968344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.
    Wang A; Green JB; Halperin JL; Piccini JP
    J Am Coll Cardiol; 2019 Aug; 74(8):1107-1115. PubMed ID: 31439220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.